# Heron Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Oct 17, 2025

- Company: [Heron Therapeutics, Inc.](/companies/hrtx.md) (CIK 818033)
- Form: SCHEDULE 13D/A
- Filed: 2025-10-17
- Accepted by EDGAR: Oct 17, 2025, 18:02 ET
- Period: not reported
- Accession: 0000902664-25-004460
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/818033/000090266425004460/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/818033/000090266425004460/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/818033/000090266425004460/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Oct 17, 2025.
Source: SEC EDGAR, the filing index for accession 0000902664-25-004460. Last ingested by Listed: Oct 27, 2026, 17:10 ET. No prices; not investment advice.